A novel coronavirus, which has been designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan China and …
CC Lai, IT Chen, CM Chao, PI Lee, WC Ko… - Expert review of …, 2021 - Taylor & Francis
Introduction Several vaccine candidates have been developed using different platforms, including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus …
VM Vashishtha, P Kumar - Expert Review of Vaccines, 2022 - Taylor & Francis
The Coronavirus Disease-2019 (COVID-19) pandemic has caused immeasurable human suffering and economic harm. However, unprecedented global will and collaboration among …
BR Bloom, GJ Nowak, W Orenstein - New England Journal of …, 2020 - Mass Medical Soc
“When Will We Have a Vaccine?” People inquiring about Covid-19 vaccines often want to know when the public can be confident that available vaccines are safe and effective, when …
B Eroglu, RF Nuwarda, I Ramzan, V Kayser - Vaccines, 2021 - mdpi.com
The COVID-19 pandemic has shaken the world since early 2020 and its health, social, economic, and societal negative impacts at the global scale have been catastrophic. Since …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus causing a global pandemic. Coronaviruses are a large family of single-stranded ribonucleic …
ABSTRACT Introduction Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2), has quickly spread around the world …
Abstract Coronavirus disease 2019 (COVID-19), the deadly disease caused by SARS-CoV- 2 (severe acute respiratory syndrome coronavirus 2) is a global pandemic that has severely …
N Tzenios, M Chahine, M Tazanios - … of the Medical Academy and other …, 2023 - sjmas.com
The first case of COVID-19 a coronavirus disease, was reported in December 2019 in Wuhan, China, and spread globally. Severe acute respiratory syndrome coronavirus 2 …